Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B West

Showing results (311-320 of 1,364) with videos related to

Pageof 137
Sort By:
Genome Medicine|October 21, 2017
Breathing new life into an old target: pulmonary disease drugs for Parkinson's disease therapyHisham Abdelmotilib, Andrew B West
Frontiers in Neuroscience|September 9, 2020
Pharmacodynamic Biomarkers for Emerging LRRK2 TherapeuticsKaela Kelly, Andrew B West
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 3, 2008
Last word on Point:Counterpoint: Gravity is/is not the major factor determining the distribution of blood flow in the human lungMichael Hughes, John B West
Biochemical Society Transactions|March 7, 2019
Caught in the act: LRRK2 in exosomesShijie Wang, Andrew B West
The Journal of Pharmacy and Pharmacology|September 1, 1973
Letter: Prostaglandins as regulators of bradykinin responsesG Thomas, G B West
The Journal of Pharmacy and Pharmacology|September 1, 1973
Letter: The action of anti-inflammatory drugs in two models of inflammationG Thomas, G B West
Journal of Clinical Gastroenterology|December 1, 1992
Diversion colitis--20 years a-growingS Haque, A B West
Seminars in Diagnostic Pathology|December 9, 1998
Differential diagnosis of bile duct injury and ductopeniaA B West, R Chatila
Lancet (London, England)|August 13, 1988
Categories of drug allergyP Kallós, G B West
Biochemical Society Transactions|April 4, 2023
The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's diseaseSamuel Strader, Andrew B West
Pageof 137

Showing results (311-320 of 1,364) with videos related to

Sort By:
Pageof 137
Genome Medicine|October 21, 2017
Breathing new life into an old target: pulmonary disease drugs for Parkinson's disease therapyHisham Abdelmotilib, Andrew B West
Frontiers in Neuroscience|September 9, 2020
Pharmacodynamic Biomarkers for Emerging LRRK2 TherapeuticsKaela Kelly, Andrew B West
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 3, 2008
Last word on Point:Counterpoint: Gravity is/is not the major factor determining the distribution of blood flow in the human lungMichael Hughes, John B West
Biochemical Society Transactions|March 7, 2019
Caught in the act: LRRK2 in exosomesShijie Wang, Andrew B West
The Journal of Pharmacy and Pharmacology|September 1, 1973
Letter: Prostaglandins as regulators of bradykinin responsesG Thomas, G B West
The Journal of Pharmacy and Pharmacology|September 1, 1973
Letter: The action of anti-inflammatory drugs in two models of inflammationG Thomas, G B West
Journal of Clinical Gastroenterology|December 1, 1992
Diversion colitis--20 years a-growingS Haque, A B West
Seminars in Diagnostic Pathology|December 9, 1998
Differential diagnosis of bile duct injury and ductopeniaA B West, R Chatila
Lancet (London, England)|August 13, 1988
Categories of drug allergyP Kallós, G B West
Biochemical Society Transactions|April 4, 2023
The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's diseaseSamuel Strader, Andrew B West
Pageof 137